A nanolaser known as the spaser can serve as a biocompatible probe capable of finding cancer cells
A nanolaser known as the spaser can serve as a super-bright, water-soluble, biocompatible probe capable of finding metastasized cancer cells in the blood stream and then killing these cells, according to a new research study. The study found the spaser can be used as an optical probe and when ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - September 7, 2017 Category: Science Source Type: video
Seattles Hub for Industry-driven Nanotechnology Education
A student enrolled in a Seattles Hub for Industry-driven Nanotechnology Education (SHINE) program looks at a microelectromechanical systems (MEMS) device.
More about this image
Supported by the National Science Foundation's Advanced Technological Education program, SHINE promotes ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - September 3, 2017 Category: Science Source Type: video
Nanotechnology Applications and Career Knowledge Network
Students enrolled in Nanotechnology Applications and Career Knowledge (NACK) Network programs gain valuable hands-on, industry endorsed skills.
More about this image
Supported by the National Science Foundation's Advanced Technological Education program, the NACK Network has assisted ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - September 2, 2017 Category: Science Source Type: video
TRACO 2017: Pancreatic cancer and Nanotechnology
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 8, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017: Epigenetics and Case reports
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 8, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017: Functional genomics and HIV
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 8, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017: Non-SCLC and HSP90 chaperone
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 8, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017: Cervical cancer and genomics
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 8, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017: Epidemiology and Health disparities
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 7, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017: Breast cancer and SCLC
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 7, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017: Lymphoma and Small molecules
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 7, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017: Radiation oncology and Topoisomerase
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 7, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017: Prostate cancer and TGF beta
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - August 7, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017 - Immune checkpoints and Ovarian cancer
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - July 18, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
TRACO 2017 - Clinical trials and Precision medicine
Translational Research in Clinical Oncology (TRACO)
Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation seq...
Source: Videocast - All Events - July 18, 2017 Category: General Medicine Tags: Upcoming Events Source Type: video
